Literature DB >> 1572986

Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from the United States and Southeast Asia.

S D Putnam1, B S Lavin, J R Stone, E C Oldfield, D G Hooper.   

Abstract

Presently, most Neisseria gonorrhoeae testing is based on beta-lactamase tests and agar dilution with common therapeutic agents. The National Committee for Clinical Laboratory Standards (NCCLS) recently described a disk diffusion test that produced results similar to the reference agar dilution method for the antibiotic susceptibility of N. gonorrhoeae. We obtained 71 gonococcal isolates from active-duty males aboard a United States Navy vessel while deployed in the Western Pacific during 1989. In addition, 47 isolates of N. gonorrhoeae were obtained from sexually transmitted disease clinics within the branch clinic operations of the Naval Hospital, San Diego (SD), and tested. Antibiotic susceptibility tests by using the NCCLS agar dilution and disk diffusion techniques were compared. Among the Southeast Asia (SEA) isolates, 47% were beta-lactamase producers compared with 10.5% of the SD isolates. The mean MICs (SEA/SD) in micrograms per milliliter for both groups were as follows: penicillin, 88/15; tetracycline, 2.2/0.95; erythromycin, 1.2/0.49; ceftriaxone, 0.016/0.012; cefotaxime, 0.034/0.03; cefuroxime, 0.44/0.17; cefoxitin, 1.3/0.97; spectinomycin, 150/131; ciprofloxacin, 0.07/0.034; norfloxacin, 0.77/0.29; lomefloxacin, 0.15/0.0.056; and ofloxacin, 0.07/0.036. The established NCCLS interpretive criteria for both susceptibility methods appear applicable to domestic gonococcal strains. However, modifications may be necessary for the more antimicrobial agent-resistant SEA isolates on the basis of the clinical success and cure rates following the indicated single-dose regimens for the geographic region.

Entities:  

Mesh:

Year:  1992        PMID: 1572986      PMCID: PMC265196          DOI: 10.1128/jcm.30.4.974-980.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline.

Authors:  J S Knapp; J M Zenilman; J W Biddle; G H Perkins; W E DeWitt; M L Thomas; S R Johnson; S A Morse
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

2.  Spectinomycin-resistant penicillinase-producing Neisseria gonorrhoeae.

Authors:  W A Ashford; D W Potts; H J Adams; J C English; S R Johnson; J W Biddle; C Thornsberry; H W Jaffe
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

Review 3.  Tetracycline-resistant Neisseria gonorrhoeae.

Authors:  J Heritage; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

4.  Beta-lactamase-producing, penicillin-resistant gonococcus.

Authors:  I Phillips
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

5.  Evidence for two distinct types of penicillinase-producing Neisseria gonorrhoeae.

Authors:  P L Perine; C Thornsberry; W Schalla; J Biddle; M S Siegel; K H Wong; S E Thompson
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

6.  Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.

Authors:  R N Jones; P C Fuchs; J A Washington; T L Gavan; P R Murray; E H Gerlach; C Thornsberry
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Nov-Dec       Impact factor: 2.803

7.  Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

Authors:  P C Fuchs; A L Barry; C Baker; P R Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

8.  Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines.

Authors:  R N Jones; E H Gerlach; F P Koontz; P R Murray; M A Pfaller; J A Washington; M E Erwin; C C Knapp
Journal:  Diagn Microbiol Infect Dis       Date:  1991 Sep-Oct       Impact factor: 2.803

9.  Spectinomycin-resistant Neisseria gonorrhoeae.

Authors:  C Thornsberry; H Jaffee; S T Brown; T Edwards; J W Biddle; S E Thompson
Journal:  JAMA       Date:  1977-05-30       Impact factor: 56.272

10.  Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from a military population in San Diego.

Authors:  T J Papadimos; J Escamilla; R A Batchelor; E W Lane; J W Biddle
Journal:  Sex Transm Dis       Date:  1988 Oct-Dec       Impact factor: 2.830

View more
  10 in total

1.  Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.

Authors:  M E Erwin; R N Jones
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  Antimicrobial susceptibility, auxotype and plasmid content of Neisseria gonorrhoeae in northern Tanzania: emergence of high level plasmid mediated tetracycline resistance.

Authors:  B West; J Changalucha; H Grosskurth; P Mayaud; R M Gabone; G Ka-Gina; D Mabey
Journal:  Genitourin Med       Date:  1995-02

3.  Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.

Authors:  J S Knapp; J A Washington; L J Doyle; S W Neal; M C Parekh; R J Rice
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

4.  Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin.

Authors:  B U Bhuiyan; M Rahman; M R Miah; S Nahar; N Islam; M Ahmed; K M Rahman; M J Albert
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

Review 5.  The epidemiology of bacterial resistance to quinolones.

Authors:  J F Acar; T F O'Brien; F W Goldstein; R N Jones
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.

Authors:  J S Knapp; J A Hale; S W Neal; K Wintersheid; R J Rice; W L Whittington
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

Review 7.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.

Authors:  T Fekete
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

8.  Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii.

Authors:  J S Knapp; R Ohye; S W Neal; M C Parekh; H Higa; R J Rice
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

9.  Antimicrobial susceptibilities of Neisseria gonorrhoeae strains representing five distinct resistance phenotypes.

Authors:  R J Rice; J S Knapp
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

Review 10.  Fluoroquinolone resistance in Neisseria gonorrhoeae.

Authors:  J S Knapp; K K Fox; D L Trees; W L Whittington
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.